Position in NVS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$753,666
+$26,271 QoQ
Shares Held
4,809
+1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#722
of 1,603 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nilsine Partners, LLC holds $35,772,221 across 11 Drug Manufacturers - General names. NVS ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,082 | $13,292,084 | |
| 2 | JNJ |
Johnson & Johnson
|
23,855 | $6,058,454 | |
| 3 | MRK |
Merck & Co., Inc.
|
26,144 | $3,359,504 | |
| 4 | NVO |
Novo Nordisk A S
|
69,503 | $3,331,973 | |
| 5 | AMGN |
Amgen Inc
|
9,193 | $3,328,969 | |
| 6 | ABBV |
AbbVie Inc.
|
10,103 | $2,542,318 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
16,624 | $2,100,276 | |
| 8 | NVS |
Novartis AG
This page
|
4,809 | $753,666 |
All Filings in NVS
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $753,666 | 4,809 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $727,395 | 4,762 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $699,138 | 5,071 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $636,583 | 4,964 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $604,323 | 4,994 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $559,406 | 5,018 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $521,970 | 5,364 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $619,267 | 5,384 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $616,296 | 5,789 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $549,329 | 5,679 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $596,227 | 5,905 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $965,327 | 9,477 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $951,984 | 9,434 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $862,592 | 9,376 | Shares | Sole | 2023-05-10 | |
| No filing history on record for this holder in this stock. | ||||||